Park JungHyun, Baek Su Jin, Baek So Hye, Kim Eung Don
Department of Anesthesiology and Pain Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 21431, Korea.
Department of Anesthesiology and Pain Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 34943, Korea.
J Clin Med. 2019 Mar 7;8(3):323. doi: 10.3390/jcm8030323.
Despite the high frequency of nerve blocks in the acute phase of herpes zoster, factors associated with intervention, such as response to epidural block, have not been analyzed as predictive factors of postherpetic neuralgia (PHN). To determine the predictive factors of progression to PHN in the presence of interventions, we analyzed the medical records of 145 patients who underwent transforaminal epidural injection (TFEI) in the acute phase of herpes zoster. A total volume of 5 mL (a mixture of 0.5% lidocaine and 5 mg dexamethasone) was injected during TFEI. Corticosteroid was used only for the first TFEI. Clinical data of age, sex, involved dermatome, presence of comorbidity, time from zoster onset to first TFEI, numerical rating scale (NRS) before TFEI, NRS at 1 week and 1, 3, and 6 months after the first TFEI, and number of TFEI were collected and analyzed. Through multivariate logistic regression analysis, pain improvement less than 50% at 1 week after the first TFEI was a strong predictive factor of progression of PHN at all time points. Response to TFEI appears to be a stronger predictive factor of progression to PHN than patient factors of sex, age, degree of initial pain, and presence of co-morbidity.
尽管在带状疱疹急性期神经阻滞的应用频率很高,但诸如硬膜外阻滞反应等与干预相关的因素尚未作为疱疹后神经痛(PHN)的预测因素进行分析。为了确定在存在干预措施的情况下进展为PHN的预测因素,我们分析了145例在带状疱疹急性期接受经椎间孔硬膜外注射(TFEI)患者的病历。TFEI期间共注射5 mL(0.5%利多卡因和5 mg地塞米松的混合物)。皮质类固醇仅用于首次TFEI。收集并分析了年龄、性别、受累皮节、合并症情况、从带状疱疹发作到首次TFEI的时间、TFEI前的数字评分量表(NRS)、首次TFEI后1周、1、3和6个月时的NRS以及TFEI次数等临床数据。通过多因素逻辑回归分析,首次TFEI后1周疼痛改善小于50%是所有时间点PHN进展的强预测因素。TFEI反应似乎是进展为PHN比性别、年龄、初始疼痛程度和合并症等患者因素更强的预测因素。